Diabetes
Conditions
Brief summary
Ubiquitous healthcare service for elderly patients with type 2 diabetes have been developed and improved glycemic control. However, previous U-healthcare service had some limitations, which needs specific devices to check blood glucose and send it to central system. Voice inception technique based U-healthcare service is expected to improve glycemic control without specific devices. To evaluate the clinical efficacy of this system, researchers plan to compare the improvement of glycemic control, self-management, and quality of life between U-health care group (intervention) and conventional treatment group (control).
Detailed description
Ubiquitous healthcare for chronic disease such as diabetes is intensively developing field. Nowadays, various methods are tried to find the most effective and easiest way for supplying U-health care. Here, researchers are going to investigate the efficacy and safety of voice inception technique based U-healthcare service.
Interventions
DEVICEU-health care
voice inception technique based U-healthcare service
Sponsors
Seoul National University Bundang Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Type 2 diabetes * age: 60 \ 85 yrs * HbA1c: 7.0%-11.0% * Basal insulin or premixed insulin user
Exclusion criteria
* Type 1 diabetes * short acting insulin or insulin pump user * systemic corticosteroid administered within previous 6 months * history of myocardial ischemia * Heart failure, New York Heart Association (NYHA) Class II-IV * Thyroid disease with abnormal thyroid function test * Anti-obesity drugs or slimming products within previous 3 months * severe liver or kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes of HbA1c | 24 weeks |
| Glucose Variability assessed by 3 day SMBG | 24 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Hypoglycemia | 24 Weeks |
| Drug Compliance | 24 Weeks |
| Self monitoring blood glucose compliance | 24 Weeks |
| Target goal of HbA1c (< 7.5%) | 24 Weeks |
| Quality of life assessed by SF36 | 24 Weeks |
| Diabetes Self-Care Activities | 24 Weeks |
| Michigan Diabetes Knowledge Test | 24 Weeks |
| Weight change | 24 Weeks |
| Target goal of HbA1c (< 8.0%) | 24 Weeks |
Countries
South Korea
Outcome results
None listed